Literature DB >> 20615668

Subjective awareness of tardive dyskinesia and insight in schizophrenia.

R Emsley1, D J H Niehaus, P P Oosthuizen, L Koen, B Chiliza, D Fincham.   

Abstract

BACKGROUND: Lack of awareness of tardive dyskinesia (TD) and poor insight into mental illness are common in schizophrenia, raising the possibility that these phenomena are manifestations of a common underlying dysfunction.
METHODS: We investigated relationships between low awareness of TD and poor insight into mental illness in 130 patients with schizophrenia and TD. We also examined selected demographic and clinical correlates of these two phenomena.
RESULTS: Sixty-six (51%) patients had no or low awareness of TD and 94 (72%) had at least mild impairment of insight into their mental illness. Low awareness of TD was not significantly correlated with greater impairment of insight into mental illness. Regression analyses indicated that the Positive and Negative Syndrome Scale (PANSS) disorganised factor (β=0.72, t=11.88, p<0.01) accounted for 52% of the variance in insight into mental illness (adjusted R(2)=0.55) (F[2, 127]=81.00, p<0.01) and the Extrapyramidal Symptom Rating Scale (ESRS) dyskinesia subscale score (β=0.47, t=6.80, p<0.01), PANSS disorganised factor (β=-0.26, t=-3.73, p<0.01), and ESRS parkinsonism subscale score (β=0.31, t=4.55, p<0.01) together accounted for 37% of the variance in awareness of TD (adjusted R(2)=0.37) (F[3, 126]=26.87, p<0.01).
CONCLUSION: The two phenomena appear to be dissociated, and may be domain-specific.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615668     DOI: 10.1016/j.eurpsy.2009.12.006

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  6 in total

Review 1.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

2.  Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder.

Authors:  P Roberto Bakker; Izaäk W de Groot; Jim van Os; Peter N van Harten
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 3.  Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Marco Solmi; Giorgio Pigato; John M Kane; Christoph U Correll
Journal:  Drug Des Devel Ther       Date:  2018-05-14       Impact factor: 4.162

4.  Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.

Authors:  Mark Stacy; Martha Sajatovic; John M Kane; Andrew J Cutler; Grace S Liang; Christopher F O'Brien; Christoph U Correll
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

5.  Improving Self-Awareness of Motor Symptoms in Patients With Parkinson's Disease by Using Mindfulness - A Study Protocol for a Randomized Controlled Trial.

Authors:  Timo Marcel Buchwitz; Franziska Maier; Andrea Greuel; Carsten Eggers
Journal:  Front Psychol       Date:  2020-04-17

6.  Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis.

Authors:  Bettina Balint; Helen Killaspy; Louise Marston; Thomas Barnes; Anna Latorre; Eileen Joyce; Caroline S Clarke; Rosa De Micco; Mark J Edwards; Roberto Erro; Thomas Foltynie; Rachael M Hunter; Fiona Nolan; Anette Schrag; Nick Freemantle; Yvonne Foreshaw; Nicholas Green; Kailash P Bhatia; Davide Martino
Journal:  BJPsych Open       Date:  2018-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.